Interested in becoming a member?
ASLTIP’s membership has been growing rapidly since 1989. We are a support organisation run by our members. The executive board is always grateful for new members and new ideas.
Apply for a membership
New results have emerged from research into stem cell transplantation in mice, suggesting that injected human stem cells could stimulate remyelinationand help to reduce inflammation in the spinal cord.
This type of therapy isn’t planned for testing in people, but could help researchers find new ways to repair the myelin damage that occurs in MS.
While the results from this study are interesting and encouraging, stem cells in MS are still experimental. It’s important to note that there is no proven stem cell therapy available for MS anywhere in the world.
New results have emerged from research into stem cell transplantation in mice, suggesting that injected human stem cells could stimulate remyelinationand help to reduce inflammation in the spinal cord.
This type of therapy isn’t planned for testing in people, but could help researchers find new ways to repair the myelin damage that occurs in MS.
While the results from this study are interesting and encouraging, stem cells in MS are still experimental. It’s important to note that there is no proven stem cell therapy available for MS anywhere in the world.
New results have emerged from research into stem cell transplantation in mice, suggesting that injected human stem cells could stimulate remyelinationand help to reduce inflammation in the spinal cord.
This type of therapy isn’t planned for testing in people, but could help researchers find new ways to repair the myelin damage that occurs in MS.
While the results from this study are interesting and encouraging, stem cells in MS are still experimental. It’s important to note that there is no proven stem cell therapy available for MS anywhere in the world.
New results have emerged from research into stem cell transplantation in mice, suggesting that injected human stem cells could stimulate remyelinationand help to reduce inflammation in the spinal cord.
This type of therapy isn’t planned for testing in people, but could help researchers find new ways to repair the myelin damage that occurs in MS.
While the results from this study are interesting and encouraging, stem cells in MS are still experimental. It’s important to note that there is no proven stem cell therapy available for MS anywhere in the world.
ASLTIP’s membership has been growing rapidly since 1989. We are a support organisation run by our members. The executive board is always grateful for new members and new ideas.
Apply for a membership